Nanjing Immunophage Biotech
As of the edition of 20 October 2026, Nanjing Immunophage Biotech runs 3 drugs.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 3 |
| Total | 3 |
Where its trials are
- Immune system: 2 trials led
- Skin and connective tissue: 2 trials led
- Digestive system: 1 trials led